AR054845A1 - Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen - Google Patents
Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienenInfo
- Publication number
- AR054845A1 AR054845A1 ARP060103065A ARP060103065A AR054845A1 AR 054845 A1 AR054845 A1 AR 054845A1 AR P060103065 A ARP060103065 A AR P060103065A AR P060103065 A ARP060103065 A AR P060103065A AR 054845 A1 AR054845 A1 AR 054845A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- substituted
- heteroaryl
- aryl
- substituent selected
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000003107 substituted aryl group Chemical group 0.000 abstract 2
- 101100439662 Arabidopsis thaliana CHR5 gene Proteins 0.000 abstract 1
- 101100134927 Gallus gallus COR8 gene Proteins 0.000 abstract 1
- 108091000080 Phosphotransferase Proteins 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 102000020233 phosphotransferase Human genes 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Se refiere a heterociclos dihidropiridina-condensados sustituidos utiles para el tratamiento de enfermedad de cáncer, especialmente para prevenir la division de células cancerígenas. Estos compuestos actuan como inhibidores de Aurora A y/o B quinasas. Reivindicacion 1: Compuesto correspondiente a la formula general (1) que se muestra a continuacion, en la que: R1 representa H, alquilo, arilo, heteroarilo, alquilo sustituido, arilo sustituido, o heteroarilo sustituido; R2 representa arilo sustituido o heteroarilo sustituido; R3 representa H o R4; X es NH o CR7; Y, Y' e Y''; i) cada uno representa independientemente un sustituyente seleccionado entre CH2, CHR5, CR5R6, C=O, O, S, NH y NR7; o ii) juntos representan un sustituyente seleccionado entre un resto de cadena -CH2-O-(C=O)-, -(CH2)4- y -(CH2)2-; cada uno de R4 y R7 representa independientemente un sustituyente seleccionado entre: R8, -COOR8, COR8 y CONHR8; cada uno de R5 y R6 representa independientemente R8; R8 representa H o uno de los siguientes opcionalmente sustituido: -alquilo, -alquil-alquileno, -alquileno, -heterocicloalquilo, -cicloalquilo, -arilo, -heteroarilo, -alquil-heterocicloalquilo, -alquil-cicloalquilo, -alquil-arilo, o -alquil- heteroarilo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05291558A EP1746097B1 (en) | 2005-07-20 | 2005-07-20 | 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR054845A1 true AR054845A1 (es) | 2007-07-18 |
Family
ID=35510894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060103065A AR054845A1 (es) | 2005-07-20 | 2006-07-18 | Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen |
Country Status (37)
| Country | Link |
|---|---|
| US (1) | US8163768B2 (es) |
| EP (2) | EP1746097B1 (es) |
| JP (2) | JP2009501778A (es) |
| KR (1) | KR101286796B1 (es) |
| CN (1) | CN101243087B (es) |
| AR (1) | AR054845A1 (es) |
| AT (2) | ATE455115T1 (es) |
| AU (1) | AU2006273692B8 (es) |
| BR (1) | BRPI0614002A2 (es) |
| CA (1) | CA2615700C (es) |
| CR (1) | CR9663A (es) |
| CY (1) | CY1109964T1 (es) |
| DE (1) | DE602005018911D1 (es) |
| DK (1) | DK1746097T3 (es) |
| DO (1) | DOP2006000175A (es) |
| EA (1) | EA016815B1 (es) |
| EC (1) | ECSP078062A (es) |
| ES (1) | ES2339676T3 (es) |
| HN (1) | HN2008000088A (es) |
| HR (1) | HRP20100195T1 (es) |
| IL (1) | IL188861A0 (es) |
| MA (1) | MA29634B1 (es) |
| MX (1) | MX2008000902A (es) |
| MY (1) | MY148617A (es) |
| NO (1) | NO20080831L (es) |
| NZ (1) | NZ592766A (es) |
| PE (2) | PE20100718A1 (es) |
| PL (1) | PL1746097T3 (es) |
| PT (1) | PT1746097E (es) |
| RS (1) | RS51351B (es) |
| SI (1) | SI1746097T1 (es) |
| TN (1) | TNSN08020A1 (es) |
| TW (1) | TWI386411B (es) |
| UA (1) | UA98928C2 (es) |
| UY (1) | UY29685A1 (es) |
| WO (1) | WO2007012972A2 (es) |
| ZA (1) | ZA200800542B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2945535B1 (fr) * | 2009-05-18 | 2011-06-10 | Sanofi Aventis | Compose anticancereux et composition pharmaceutique le contenant |
| FR2967413A1 (fr) * | 2010-11-17 | 2012-05-18 | Sanofi Aventis | Compose 8-oxo-9-[3-(1h-benzimidazol-2-yloxy)-phenyl]-4,5,6,7,8,9-hexahydro-2h-pyrrolo[3,4-b]quinoline-3-carboxylate d'ethyle, sel, forme cristalline, co-cristal, formulation, procedes de preparation, application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteur des kinases aurora. |
| TR201807023T4 (tr) | 2012-05-15 | 2018-06-21 | Novartis Ag | Abl1, abl2 ve bcr- abl1 aktivitesinin inhibe edilmesi için benzamid türevleri. |
| EP2861576B1 (en) | 2012-05-15 | 2018-01-10 | Novartis AG | Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1 |
| EP2858988B1 (en) | 2012-05-15 | 2018-02-28 | Novartis AG | Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1 |
| KR102190848B1 (ko) | 2012-05-15 | 2020-12-15 | 노파르티스 아게 | Abl1, abl2 및 bcr-abl1의 활성을 억제하기 위한 화합물 및 조성물 |
| CA2887701C (en) | 2012-10-12 | 2020-12-15 | The Broad Institute, Inc. | Gsk3 inhibitors and methods of use thereof |
| AU2015360416A1 (en) | 2014-12-10 | 2017-06-08 | Massachusetts Institute Of Technology | Fused 1,3-azole derivatives useful for the treatment of proliferative diseases |
| CA2983314C (en) | 2015-04-30 | 2024-11-12 | Memorial Sloan-Kettering Cancer Center | Mitragynine analogues and their uses |
| RU2619932C1 (ru) * | 2015-11-25 | 2017-05-22 | федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет" (ФГБОУ ВО "ВГУ") | ЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-а]ПИРИДО[3,4-е]ПИРИМИДИНЫ И ИХ ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ПРОТЕИНКИНАЗ |
| WO2017124087A1 (en) | 2016-01-15 | 2017-07-20 | Memorial Sloan-Kettering Cancer Center | Anti-parasitic compounds and uses thereof |
| CA3012846A1 (en) | 2016-02-16 | 2017-08-24 | Massachusetts Institute Of Technology | Max binders as myc modulators and uses thereof |
| CA3058198A1 (en) | 2017-04-05 | 2018-10-11 | The Broad Institute, Inc. | Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof |
| WO2018209030A1 (en) | 2017-05-12 | 2018-11-15 | Rti International | Diarylureas as cb1 allosteric modulators |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002508324A (ja) * | 1997-12-13 | 2002-03-19 | ブリストル−マイヤーズ スクイブ カンパニー | サイクリン依存性キナーゼ阻害剤としてのピラゾロ［３，４−ｂ］ピリジンの使用 |
| JP2003529552A (ja) | 1999-11-19 | 2003-10-07 | アボット・ラボラトリーズ | 三環性ジヒドロピリミジンカリウムチャンネル開口剤 |
| US6538004B2 (en) | 2000-03-03 | 2003-03-25 | Abbott Laboratories | Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| EP1259510B1 (en) | 2000-03-03 | 2004-06-02 | Abbott Laboratories | Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| CN1630656A (zh) | 2001-02-02 | 2005-06-22 | 三菱制药株式会社 | 二氢吡唑并吡啶化合物及其制药用途 |
| FR2823854A1 (fr) | 2001-04-18 | 2002-10-25 | Centre Nat Rech Scient | Nouveau procede de criblage d'inhibiteurs de la liaison entre la proteine oxyde nitrique synthase neuronale et la proteine inhibitrice de l'oxyde nitrique synthase neuronale |
| FR2825091B1 (fr) * | 2001-05-23 | 2003-07-04 | Servier Lab | Nouveaux derives tricycliques de dihydro-quinnoleines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US7037902B2 (en) * | 2002-07-03 | 2006-05-02 | Receptron, Inc. | Affinity small molecules for the EPO receptor |
| SE0301371D0 (sv) | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | New Compounds |
| BRPI0411364A (pt) * | 2003-06-13 | 2006-07-25 | Zentaris Gmbh | compostos tendo atividade inibidora de fosfatidilinositol 3-cinase e métodos de uso dos mesmos |
-
2005
- 2005-07-20 ES ES05291558T patent/ES2339676T3/es not_active Expired - Lifetime
- 2005-07-20 SI SI200530964T patent/SI1746097T1/sl unknown
- 2005-07-20 DE DE602005018911T patent/DE602005018911D1/de not_active Expired - Lifetime
- 2005-07-20 RS RSP-2010/0159A patent/RS51351B/sr unknown
- 2005-07-20 EP EP05291558A patent/EP1746097B1/en not_active Expired - Lifetime
- 2005-07-20 AT AT05291558T patent/ATE455115T1/de active
- 2005-07-20 PL PL05291558T patent/PL1746097T3/pl unknown
- 2005-07-20 DK DK05291558.4T patent/DK1746097T3/da active
- 2005-07-20 PT PT05291558T patent/PT1746097E/pt unknown
-
2006
- 2006-07-18 WO PCT/IB2006/002734 patent/WO2007012972A2/en not_active Ceased
- 2006-07-18 PE PE2010000153A patent/PE20100718A1/es not_active Application Discontinuation
- 2006-07-18 PE PE2006000862A patent/PE20070212A1/es not_active Application Discontinuation
- 2006-07-18 ZA ZA200800542A patent/ZA200800542B/xx unknown
- 2006-07-18 AR ARP060103065A patent/AR054845A1/es not_active Application Discontinuation
- 2006-07-18 EP EP06808922A patent/EP1910366B1/en active Active
- 2006-07-18 EA EA200800374A patent/EA016815B1/ru not_active IP Right Cessation
- 2006-07-18 MY MYPI20063429A patent/MY148617A/en unknown
- 2006-07-18 CN CN2006800303826A patent/CN101243087B/zh not_active Expired - Fee Related
- 2006-07-18 KR KR1020087003945A patent/KR101286796B1/ko not_active Expired - Fee Related
- 2006-07-18 AT AT06808922T patent/ATE521611T1/de not_active IP Right Cessation
- 2006-07-18 AU AU2006273692A patent/AU2006273692B8/en not_active Ceased
- 2006-07-18 JP JP2008522098A patent/JP2009501778A/ja not_active Withdrawn
- 2006-07-18 UA UAA200802146A patent/UA98928C2/ru unknown
- 2006-07-18 BR BRPI0614002-5A patent/BRPI0614002A2/pt not_active IP Right Cessation
- 2006-07-18 NZ NZ592766A patent/NZ592766A/xx not_active IP Right Cessation
- 2006-07-18 MX MX2008000902A patent/MX2008000902A/es active IP Right Grant
- 2006-07-18 CA CA2615700A patent/CA2615700C/en not_active Expired - Fee Related
- 2006-07-19 TW TW095126453A patent/TWI386411B/zh not_active IP Right Cessation
- 2006-07-20 DO DO2006000175A patent/DOP2006000175A/es unknown
- 2006-07-20 UY UY29685A patent/UY29685A1/es unknown
-
2007
- 2007-12-27 EC EC2007008062A patent/ECSP078062A/es unknown
-
2008
- 2008-01-15 US US12/014,516 patent/US8163768B2/en active Active
- 2008-01-15 CR CR9663A patent/CR9663A/es unknown
- 2008-01-16 MA MA30580A patent/MA29634B1/fr unknown
- 2008-01-17 IL IL188861A patent/IL188861A0/en unknown
- 2008-01-18 TN TNP2008000020A patent/TNSN08020A1/en unknown
- 2008-01-21 HN HN2008000088A patent/HN2008000088A/es unknown
- 2008-02-15 NO NO20080831A patent/NO20080831L/no not_active Application Discontinuation
-
2010
- 2010-04-07 HR HR20100195T patent/HRP20100195T1/hr unknown
- 2010-04-09 CY CY20101100327T patent/CY1109964T1/el unknown
-
2012
- 2012-11-05 JP JP2012243375A patent/JP2013063987A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR054845A1 (es) | Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen | |
| PE20190656A1 (es) | Compuestos de tiazolo-piridina sustituida como inhibidores de malt1 | |
| ES2528451T3 (es) | Inhibidores de esfingosina cinasa | |
| AR078157A1 (es) | Derivados de pirazol-[4,5-d]pirrolo[2,3-b]piridina inhibidores de tirosinquinasas jak 2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer | |
| AR074343A1 (es) | Derivados de piridina y pirimidina como inhibidores de la fosfodiesterasa 10 | |
| AR074435A1 (es) | Derivados de 1,3-benzotiazol, medicamentos que los contienen y uso de los mismos en el tratamiento del cancer. | |
| CU20090070A7 (es) | Nuevos derivados de sulfonamida como antagonistas de la bradiquinina | |
| AR041739A1 (es) | Compuestos derivados -3,4-dihidro-1h-pirimido[4,5-d]pirimidin-2-ona y con actividad antiproliferativa. | |
| PE20080266A1 (es) | 4-amino-pirido[3,2-e]pirazinas, su uso como inhibidores de fosfodiesterasa 10 y procesos para su preparacion | |
| AR097431A1 (es) | Compuestos de carboxamida de furo y tienopiridina útiles como inhibidores de quinasas pim | |
| AR043508A1 (es) | 1-amino 1-h-imidazoquinolinas y su uso como inmunomoduladores | |
| AR045134A1 (es) | Compuesto de 1h - imidazo [4,5-c] piridin-ilo, composicion farmaceutica que lo comprende, proceso para prepararla, su uso para preparar dicha composicion farmaceutica, combinacion farmaceutica, uso de la combinacion farmaceutica para la preparacion de un medicamento, procedimientos para preparar dic | |
| AR055592A1 (es) | Derivados de 2-amino-5-cicloalquil-hidantoina como moduladores y/o inhibidores de la beta-secretasa(bace) | |
| AR041133A1 (es) | Pirazolopirimidinas como inhibidores de la quinasa dependientes de la ciclina | |
| AR091023A1 (es) | Inhibidores del nampt | |
| HRP20080113T3 (hr) | Supstituirani piridinilni i pirimidinilni derivati kao modulatori metabolizma i liječenje bolesti koje su s tim povezane | |
| PE20080263A1 (es) | Compuestos de pirrolo-pirimidina y sus usos | |
| AR036586A1 (es) | Nuevas dihidro-pteridinonas, procedimientos para su preparacion, su utilizacion como medicamentos y las formulaciones farmaceuticas que las contienen | |
| ECSP055535A (es) | Derivados de 1-heterociclialquil-3-sulfonilazaindol o azaindol como ligandos de 5-hidroxitriptamina-6 | |
| AR059886A1 (es) | Derivados de amidas como inhibidores de renina | |
| AR079271A1 (es) | 3,6-diazabiciclo(3.1.1)heptanos como ligandos de receptores nicotinicos neuronales de acetilcolina | |
| AR043487A1 (es) | Heterociclos fusionados de pirimidina y usos de los mismos | |
| AR041864A1 (es) | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso | |
| CO6362013A2 (es) | Derivados de rifamicina | |
| WO2006136837A3 (en) | Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |